{"nctId":"NCT04822597","briefTitle":"Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer","startDateStruct":{"date":"2021-04-23","type":"ACTUAL"},"conditions":["Breast Cancer","Sentinel Lymph Node","Breast Neoplasms","Breast Cancer Female"],"count":167,"armGroups":[{"label":"Ice Pack","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Ice pack"]},{"label":"Lidocaine Patch","type":"EXPERIMENTAL","interventionNames":["Drug: Lidocaine patch"]},{"label":"Buzzy(R)","type":"EXPERIMENTAL","interventionNames":["Device: Buzzy(R)","Other: Ice pack"]},{"label":"Lidocaine Patch and Buzzy(R)","type":"EXPERIMENTAL","interventionNames":["Drug: Lidocaine patch","Device: Buzzy(R)","Other: Ice pack"]}],"interventions":[{"name":"Lidocaine patch","otherNames":["topical lidocaine 4%"]},{"name":"Buzzy(R)","otherNames":["vibrating distraction device","therapeutic vibrator"]},{"name":"Ice pack","otherNames":["ice","coolant"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* greater than or equal to 18 years of age\n* biopsy proven breast cancer\n* standard radiotracer injection (intradermal injection in the upper outer quadrant of the involved breast)\n* radiotracer injection occurs on the same day as sentinel lymph node surgery\n\nExclusion Criteria:\n\n* males\n* pregnancy\n* local anesthetic allergy or active use of the following medications:\n\n  * Abametapir (risk X)\n  * Conivaptan (risk X)\n  * Fusidic Acid (risk X)\n  * Idelalisib (risk X)\n  * Mifepristone (risk D)\n  * Stiripentol (risk D)\n  * Amiodarone (risk C)\n  * Dofetilide (risk C)\n  * Dronedarone (risk C)\n  * Ibutilide (risk C)\n  * Sotalol (risk C)\n  * Vernakalant (risk C)\n* Non-English speaking/reading\n* Unable to provide informed consent\n* Unable to participate with surveys\n* Undergoing radiotracer injection the day prior to surgery or intra-operatively at the time of initial surgical scheduling\n\n  * If patients are initially scheduled for same-day preoperative injection, complete all enrollment procedures (including randomization), and surgery is re-scheduled for a day prior to surgery or for intra-operative injection, they will be excluded if:\n\n    * randomized to a lidocaine patch arm (Arms C or D)\n    * re-scheduled for an intra-operative injection â€¢ Planned non-standard radiotracer injection site","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Median Post-Procedural Pain Score","description":"Post-procedural pain score on the Wong-Baker FACES scale. Scale from 0-10 with 0 being \"no pain\" and 10 being \"worst pain\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Short Form McGill Sensory Pain Score","description":"Sensory pain score out of 33 with 0 being \"no pain\" and 33 being severe sensory pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Short Form McGill Affective Pain Score","description":"Affective pain score out of 12 with 0 being \"no pain\" and 12 being severe affective pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Short Form McGill VAS Pain Score","description":"Visual analog scale pain score out of 100 with zero being \"no pain\" and 100 being \"worst possible pain\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"28","spread":null},{"groupId":"OG002","value":"27","spread":null},{"groupId":"OG003","value":"33","spread":null}]}]}]},{"type":"SECONDARY","title":"Short Form McGill Combined Pain Score","description":"Combination of outcomes 2-3. Additive total score between 0 and 45 with zero being \"no pain\" and 45 being \"severe pain\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"6","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Participant Satisfaction With Attention Paid to Complaints as Reported by Number of Participants Who Report Satisfied or Very Satisfied","description":"1-6 scale with 1 being \"very satisfied\" and 6 being \"very dissatisfied\". Reported are the number of participants satisfied or very satisfied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"42","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Participant Satisfaction With Care Provided During Injection as Reported by Number of Participants Who Report Satisfied or Very Satisfied","description":"1-6 scale with 1 being \"very satisfied\" and 6 being \"very dissatisfied\". Reported are the number of participants satisfied or very satisfied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"37","spread":null},{"groupId":"OG002","value":"42","spread":null},{"groupId":"OG003","value":"37","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Participant Satisfaction With Pain Control as Reported by Number of Participants Who Report Satisfied or Very Satisfied","description":"1-6 scale with 1 being \"very satisfied\" and 6 being \"very dissatisfied\". Reported are the number of participants satisfied or very satisfied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"36","spread":null},{"groupId":"OG003","value":"36","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Anxiety During the Injection as Measured by Number of Participants Moderately Anxious","description":"1-4 scale with 1 being \"very anxious\" and 4 being \"not at all anxious\", reported here are the number of participants rating anxiety at 2 or \"moderate\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33","spread":null},{"groupId":"OG001","value":"24","spread":null},{"groupId":"OG002","value":"32","spread":null},{"groupId":"OG003","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Recommendation of Pain Control Modality as Measured by Number of Participants Who Answered \"Yes\"","description":"\"Yes\", \"No\", \"Not sure\" with option for free response","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"31","spread":null},{"groupId":"OG002","value":"35","spread":null},{"groupId":"OG003","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Provider Perceived Ease of Administration","description":"7 point single ease question to rate ease of a task. 1 being \"very difficult\" and 7 being \"very easy\". This is the provider's perception of the how easy the intervention was to administer.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Provider Perceived Participant Pain","description":"11 point numeric rating scale for perceived pain of others. 0 being \"no pain\" and 7-10 being \"severe pain\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"4","spread":null},{"groupId":"OG003","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Provider Rank Ordering Ease of Use of Interventions","description":"End of study survey to compare providers' perceived usability of intervention. Rank ordering of interventions 1-4 with 1 being \"easiest to administer\" and 4 being \"hardest to administer\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"8","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Provider Rank Ordering Perceived Efficacy of Interventions","description":"End of study survey to compare providers' perceived efficacy of intervention. Rank ordering of interventions 1-4 with 1 being \"best pain control\" and 4 being \"least pain control\".","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"0","spread":null},{"groupId":"OG003","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"2","spread":null},{"groupId":"OG003","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"5","spread":null},{"groupId":"OG003","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":44},"commonTop":[]}}}